Huang, Xiaomeng
Qiao, Yi
Brady, Samuel W.
Factor, Rachel E.
Downs-Kelly, Erinn
Farrell, Andrew
McQuerry, Jasmine A.
Shrestha, Gajendra
Jenkins, David
Johnson, W. Evan
Cohen, Adam L.
Bild, Andrea H.
Marth, Gabor T. http://orcid.org/0000-0003-0222-1694
Funding for this research was provided by:
National Cancer Institute (U24CA209999, U54CA209978, P30CA042014)
National Institutes of Health (5T15LM007124)
Article History
Received: 15 December 2020
Accepted: 13 October 2021
First Online: 28 October 2021
Declarations
:
: The study was reviewed and approved by the human subjects IRB (#41030) of the University of Utah. Informed consent in accordance with the Declaration of Helsinki was obtained from the patient. According to the wishes of the patient and family, to honor the contribution of the patient, and after IRB approval, we named this study “The Victoria Clark Study.”
: Written informed consent was obtained for the publication of the patient’s genomic data and clinical details.
: The authors declare that they have no competing interests.